The direct answer
Antibiotics cause stomach problems because they disrupt the gut in two separate ways simultaneously. Most patients are told about neither.
The first is direct chemical irritation — antibiotic compounds are directly toxic or irritating to the gastrointestinal epithelium as they pass through. The second is systemic microbiome disruption — antibiotics kill commensal bacteria indiscriminately, collapsing the community that regulates motility, produces protective short-chain fatty acids, and maintains the intestinal barrier.
Mechanism 1 — Direct mucosal irritation
Macrolides (azithromycin, clarithromycin, erythromycin): activate motilin receptors in the gut wall, causing increased gastric and intestinal contractions. Nausea and cramping can begin within the first hour of the first dose.
Amoxicillin-clavulanate (Augmentin): clavulanic acid is responsible for a significant portion of GI irritation — more so than the amoxicillin component.
Fluoroquinolones (ciprofloxacin, levofloxacin): disrupt the gut mucosal barrier through oxidative stress and alter motility through effects on enteric nervous system function.
Metronidazole: causes direct chemical irritation, metallic taste, and CNS-mediated nausea — especially at the higher doses used in H. pylori eradication therapy.
This mechanism is immediate, dose-related, and resolves when the course ends. Taking antibiotics with food reduces the contact irritation for most classes.
Mechanism 2 — Microbiome disruption
The human gut contains an estimated 38 trillion microbial cells. Broad-spectrum antibiotics cannot distinguish between the pathogen they're prescribed for and the commensals they encounter throughout the GI tract. A 7-day course of amoxicillin-clavulanate reduces gut bacterial diversity by approximately 30–50%. Fluoroquinolones can eliminate entire bacterial families. The community that rebuilds is not the same one that was there before — and the symptoms from this disruption continue long after the drug is gone.
Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii — the bacteria that ferment dietary fibre into butyrate, propionate, and acetate — are preferentially killed. Butyrate is the primary energy source for colonocytes (colon lining cells).
Day 1–3Without butyrate, colonocytes cannot maintain the tight junction proteins that keep the intestinal barrier sealed. The gut becomes permeable — bacterial products cross into the lamina propria, triggering mucosal immune activation and NF-kB-driven inflammation.
Days 2–5Antibiotic-resistant gram-negatives — Proteobacteria, Enterobacteriaceae — expand into the ecological vacuum. In the worst cases, C. difficile proliferates and produces toxins that destroy the colonic epithelium.
Days 3–14The disrupted community takes 1–6 months to recover toward pre-antibiotic composition — and in many cases never fully returns. This is why gut symptoms recur with each subsequent stressor after an antibiotic course.
Weeks to monthsThe H. pylori irony
H. pylori eradication therapy — the most common reason Indians take multiple antibiotics simultaneously — activates both mechanisms at once: direct mucosal irritation from metronidazole, clarithromycin, and amoxicillin, and simultaneous microbiome collapse from the broad-spectrum activity. This is why H. pylori eradication therapy is consistently described by patients as among the worst antibiotic experiences they have had.
A single course of broad-spectrum antibiotics causes significant, measurable alterations in gut microbiota composition that persist for months — with some bacterial taxa absent at six months post-treatment in the absence of active recovery support.
References
- Jakobsson HE et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLOS ONE. 2010;5(3):e9836. PMID 20844596. Longitudinal study showing persistent microbiome disruption months after antibiotic courses — basis for the statement that recovery is not automatic.
- Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;474(11):1823–1836. PMID 28512250. Defines the commensal microbiome's functions — SCFA production, barrier maintenance, immune training — that antibiotic courses disrupt.
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. Context for H. pylori eradication therapy as the clinical scenario combining both antibiotic gut damage mechanisms simultaneously.